Literature DB >> 11967919

Epidemiology of Down syndrome (Trisomy 21), Hawaii, 1986-97.

Mathias B Forrester1, Ruth D Merz.   

Abstract

BACKGROUND: The live birth prevalence of Down syndrome is approximately 10 per 10,000 live births in the United States. Down syndrome prevalence has been reported to change over time and to vary by selected demographic factors.
METHODS: Data from a population-based birth defects registry in Hawaii involving 363 Down syndrome cases delivered during 1986-97 were used to calculate overall prevalence and to investigate secular trends and differences by selected demographic factors.
RESULTS: The total (live birth, fetal death, and elective termination) prevalence was 14.74 per 10,000 live births and fetal deaths. The unadjusted live birth prevalence was 8.67 per 10,000 live births. The adjusted live birth (live births and proportion of elective terminations expected to have resulted in live births) prevalence was 12.59 per 10,000 live births. No significant secular trends were observed for either total prevalence (P = 0.688) or adjusted live birth prevalence (P = 0.604). The total Down syndrome prevalence per 10,000 live births was highest for Far East Asians (22.01), followed by whites (17.06), Filipinos (15.94), and Pacific Islanders (9.21). Prevalence per 10,000 births was higher in metropolitan Honolulu (18.57) than in the rest of Hawaii (14.15). After adjusting for maternal age, however, the differences within the demographic groups were not statistically significant.
CONCLUSIONS: The live birth prevalence of Down syndrome in Hawaii during 1986-97 was lower than reported in the literature. Prevalence did not change significantly over time. Any differences in prevalence by maternal race/ethnicity and place of residence appeared to result from differences in maternal age distribution. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11967919     DOI: 10.1002/tera.10042

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  7 in total

1.  The future of neo-eugenics. Now that many people approve the elimination of certain genetically defective fetuses, is society closer to screening all fetuses for all known mutations?

Authors:  Armand Marie Leroi
Journal:  EMBO Rep       Date:  2006-12       Impact factor: 8.807

2.  Current estimate of Down Syndrome population prevalence in the United States.

Authors:  Angela P Presson; Ginger Partyka; Kristin M Jensen; Owen J Devine; Sonja A Rasmussen; Linda L McCabe; Edward R B McCabe
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

3.  Perinatal loss of Ts65Dn Down syndrome mice.

Authors:  Randall J Roper; Heidi K St John; Jessica Philip; Ann Lawler; Roger H Reeves
Journal:  Genetics       Date:  2005-09-19       Impact factor: 4.562

4.  Is the prevalence of Down syndrome births in Hawai'i increasing?

Authors:  Heather McDermott; Jean L Johnson
Journal:  Hawaii Med J       Date:  2011-04

5.  Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A.

Authors:  Stephanie James; Robert C Haight; Cassandra Hanna; Lindsey Furton
Journal:  Vaccines (Basel)       Date:  2022-07-19

6.  Expanding diagnostic testing beyond cytogenetics: implications for birth defects research and surveillance.

Authors:  Jodi M Jackson; Charlotte M Druschel; Stuart K Shapira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-11-06

7.  Influence of advanced age of maternal grandmothers on Down syndrome.

Authors:  Suttur S Malini; Nallur B Ramachandra
Journal:  BMC Med Genet       Date:  2006-01-14       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.